Captopril and atenolol combined with hydrochlorothiazide in essential hypertension.
- 1 April 1982
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 14 (S2) , 107S-111S
- https://doi.org/10.1111/j.1365-2125.1982.tb02066.x
Abstract
1 Fifty‐seven patients with mild or moderate essential hypertension, mean age 50 (range 31‐69) were randomised to treatment with either captopril or atenolol. Twenty‐six patients in each group completed the study. 2 Captopril (25‐50 mg three times daily) and atenolol (50‐100 mg once daily) caused a highly significant fall in blood pressure both supine and standing. 3 When hydrochlorothiazide (25‐50 mg once daily) was added a further fall in blood pressure was observed in both groups. 4 Captopril as single drug caused no significant change in heart rate, while atenolol significantly reduced heart rate both supine and standing. 5 Two patients were excluded from the captopril group, one because of a reversible loss of taste and the other because of dizziness. Three patients were excluded from the atenolol group, two because of bradyarrhythmias and one because of inadequate blood pressure response. 6 Both captopril and atenolol were found to be effective antihypertensive agents, suitable for the treatment of essential hypertension.Keywords
This publication has 24 references indexed in Scilit:
- Captopril, an Orally Active Converting Enzyme Inhibitor, in the Treatment of Primary HypertensionActa Medica Scandinavica, 1981
- CAPTOPRIL IN THE TREATMENT OF CLINICAL HYPERTENSION AND CARDIAC FAILUREThe Lancet, 1979
- LONG-TERM EFFECTS OF CAPTOPRIL (SQ14 225) ON BLOOD-PRESSURE AND HORMONE LEVELS IN ESSENTIAL HYPERTENSIONThe Lancet, 1979
- Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis.Hypertension, 1979
- Converting enzyme inhibition with an orally active compound in hypertensive man.Hypertension, 1978
- The renin system in high blood pressure, from disbelief to reality: Converting-enzyme blockade for analysis and treatmentProgress in Cardiovascular Diseases, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977
- Angiotensin II in essential hypertension.BMJ, 1977
- Angiotensin-Converting Enzyme: Vascular Endothelial LocalizationScience, 1976